Inhibrx

Inhibrx is a clinical-stage biopharmaceutical company based in La Jolla, California, dedicated to advancing scientific innovation and excellence in the treatment of life-threatening conditions. Utilizing their expertise in protein engineering and a proprietary single-domain antibody platform, Inhibrx has developed a diverse pipeline of novel therapeutic candidates targeting conditions such as sarcoma and head and neck cancer.

The company prides itself on a flexible and agile approach to research, combining deep scientific and clinical experience with a start-up spirit to foster continual innovation. By leveraging their understanding of target biology, Inhibrx aims to bring fresh perspectives and effective solutions to the field of biotherapeutics.

Generated from the website